by The telerehabilitation market size was valued at USD 3.58 billion in 2023 and is expected to reach USD 12.90 billion by 2032, growing at a CAGR of 15.30% from 2023 to 2032.
Key Takeaways
- North America contributed more than 41% of revenue share in 2022.
- Asia Pacific is estimated to expand the fastest CAGR between 2023 and 2032.
- By component, the software segment has held the largest market share of 60% in 2022.
- By component, the hardware segment is anticipated to grow at a remarkable CAGR of 18.4% between 2023 and 2032.
- By service, the clinical therapy segment generated over 62% of revenue share in 2022.
- By service, the clinical assessment segment is expected to expand at the fastest CAGR over the projected period.
- By therapy, the physical therapy segment generated over 42% of revenue share in 2022.
- By Therapy, the occupational therapy segment is expected to expand at the fastest CAGR over the projected period.
The telerehabilitation market report offers an exclusive study of the present state expected at the market dynamics, opportunities, market scheme, growth analysis and regional outlook. The report presents energetic visions to conclude and study the market size, market aspiration, and competitive environment. The research also focuses on the important achievements of the market, research & development, and regional (country by country) growth of the leading vendors operating in the market
The study offers intricate dynamics about different aspects of the global telerehabilitation market, which aids companies operating in the market in making strategies development decisions. The study also elaborates on remarkable changes that are highly anticipated to configure growth of the global telerehabilitation market during the forecast period. It also includes a key indicator analysis that highlights growth prospects of this market and approximate statistics related to growth of the market in terms of value (US$ Mn) and volume (tons).
Sample Link @ https://www.precedenceresearch.com/sample/3619
Telerehabilitation Market Scope
| Report Coverage | Details |
| Growth Rate from 2023 to 2032 | CAGR of 15.30% |
| Market Size in 2023 | USD 3.58 Billion |
| Market Size by 2032 | USD 12.90 Billion |
| Largest Market | North America |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Segments Covered | By Component, By Services, and By Therapy |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
This study covers an elaborate segmentation of the global telerehabilitation market, along with important information and a competition outlook. The report mentions company profiles of players that are currently influence the global telerehabilitation market, wherein various developments, expansions, and winning strategies practiced and execute by leading players have been presented in detail.
Read Also: Wireless Implants Market Size To Reach USD 29.51 Bn By 2032
Recent Developments
- In January 2019, MedRisk introduced a tele-rehabilitation element to its onsite physical therapy initiative, ensuring uniform care for injured workers, irrespective of their geographical location.
- In January 2019, eWellness Healthcare Corporation, known for its cutting-edge PHZIO platform in the physical therapy and telehealth sectors, unveiled version 3.0 of its digital treatment platform, PHZIO. This release marked a significant upgrade, reflecting the company’s commitment to advancing its capabilities in the evolving landscape of digital healthcare and rehabilitation services.
Telerehabilitation Market Players
- Philips Healthcare
- Honeywell International Inc.
- InTouch Health
- Cisco Systems, Inc.
- Medtronic plc
- Tunstall Healthcare Group
- MDLive Inc.
- VeeMed
- eWellness Healthcare Corporation
- Neuro Rehab VR
- Doctor On Demand, Inc.
- GlobalMedia Group, LLC
- 3D Systems, Inc.
- Tyromotion GmbH
- Basis Science, Inc.
Segments Covered in the Report
By Component
- Hardware
- Software
By Services
- Clinical Assessment
- Clinical Therapy
By Therapy
- Physical Therapy
- Occupational Therapy
- Others
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
Research Methodology
The research methodology acquire by analysts for assemble the global telerehabilitation market report is based on detailed primary as well as secondary research. With the help of in-depth insights of the market-affiliated information that is obtained and legitimated by market-admissible resources, analysts have offered riveting observations and authentic forecasts for the global market.
During the primary research phase, analysts interviewed market stakeholders, investors, brand managers, vice presidents, and sales and marketing managers. Based on data obtained through interviews of genuine resources, analysts have emphasized the changing scenario of the global market.
For secondary research, analysts study numerous annual report declaration, white papers, market association declaration, and company websites to obtain the necessary understanding of the global telerehabilitation market.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Telerehabilitation Market
5.1. COVID-19 Landscape: Telerehabilitation Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Telerehabilitation Market, By Component
8.1. Telerehabilitation Market, by Component, 2023-2032
8.1.1 Hardware
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Software
8.1.2.1. Market Revenue and Forecast (2020-2032)
Chapter 9. Global Telerehabilitation Market, By Services
9.1. Telerehabilitation Market, by Services, 2023-2032
9.1.1. Clinical Assessment
9.1.1.1. Market Revenue and Forecast (2020-2032)
9.1.2. Clinical Therapy
9.1.2.1. Market Revenue and Forecast (2020-2032)
Chapter 10. Global Telerehabilitation Market, By Therapy
10.1. Telerehabilitation Market, by Therapy, 2023-2032
10.1.1. Physical Therapy
10.1.1.1. Market Revenue and Forecast (2020-2032)
10.1.2. Occupational Therapy
10.1.2.1. Market Revenue and Forecast (2020-2032)
10.1.3. Others
10.1.3.1. Market Revenue and Forecast (2020-2032)
Chapter 11. Global Telerehabilitation Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Component (2020-2032)
11.1.2. Market Revenue and Forecast, by Services (2020-2032)
11.1.3. Market Revenue and Forecast, by Therapy (2020-2032)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Component (2020-2032)
11.1.4.2. Market Revenue and Forecast, by Services (2020-2032)
11.1.4.3. Market Revenue and Forecast, by Therapy (2020-2032)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Component (2020-2032)
11.1.5.2. Market Revenue and Forecast, by Services (2020-2032)
11.1.5.3. Market Revenue and Forecast, by Therapy (2020-2032)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Component (2020-2032)
11.2.2. Market Revenue and Forecast, by Services (2020-2032)
11.2.3. Market Revenue and Forecast, by Therapy (2020-2032)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Component (2020-2032)
11.2.4.2. Market Revenue and Forecast, by Services (2020-2032)
11.2.4.3. Market Revenue and Forecast, by Therapy (2020-2032)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Component (2020-2032)
11.2.5.2. Market Revenue and Forecast, by Services (2020-2032)
11.2.5.3. Market Revenue and Forecast, by Therapy (2020-2032)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Component (2020-2032)
11.2.6.2. Market Revenue and Forecast, by Services (2020-2032)
11.2.6.3. Market Revenue and Forecast, by Therapy (2020-2032)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Component (2020-2032)
11.2.7.2. Market Revenue and Forecast, by Services (2020-2032)
11.2.7.3. Market Revenue and Forecast, by Therapy (2020-2032)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Component (2020-2032)
11.3.2. Market Revenue and Forecast, by Services (2020-2032)
11.3.3. Market Revenue and Forecast, by Therapy (2020-2032)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Component (2020-2032)
11.3.4.2. Market Revenue and Forecast, by Services (2020-2032)
11.3.4.3. Market Revenue and Forecast, by Therapy (2020-2032)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Component (2020-2032)
11.3.5.2. Market Revenue and Forecast, by Services (2020-2032)
11.3.5.3. Market Revenue and Forecast, by Therapy (2020-2032)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Component (2020-2032)
11.3.6.2. Market Revenue and Forecast, by Services (2020-2032)
11.3.6.3. Market Revenue and Forecast, by Therapy (2020-2032)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Component (2020-2032)
11.3.7.2. Market Revenue and Forecast, by Services (2020-2032)
11.3.7.3. Market Revenue and Forecast, by Therapy (2020-2032)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Component (2020-2032)
11.4.2. Market Revenue and Forecast, by Services (2020-2032)
11.4.3. Market Revenue and Forecast, by Therapy (2020-2032)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Component (2020-2032)
11.4.4.2. Market Revenue and Forecast, by Services (2020-2032)
11.4.4.3. Market Revenue and Forecast, by Therapy (2020-2032)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Component (2020-2032)
11.4.5.2. Market Revenue and Forecast, by Services (2020-2032)
11.4.5.3. Market Revenue and Forecast, by Therapy (2020-2032)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Component (2020-2032)
11.4.6.2. Market Revenue and Forecast, by Services (2020-2032)
11.4.6.3. Market Revenue and Forecast, by Therapy (2020-2032)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Component (2020-2032)
11.4.7.2. Market Revenue and Forecast, by Services (2020-2032)
11.4.7.3. Market Revenue and Forecast, by Therapy (2020-2032)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Component (2020-2032)
11.5.2. Market Revenue and Forecast, by Services (2020-2032)
11.5.3. Market Revenue and Forecast, by Therapy (2020-2032)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Component (2020-2032)
11.5.4.2. Market Revenue and Forecast, by Services (2020-2032)
11.5.4.3. Market Revenue and Forecast, by Therapy (2020-2032)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Component (2020-2032)
11.5.5.2. Market Revenue and Forecast, by Services (2020-2032)
11.5.5.3. Market Revenue and Forecast, by Therapy (2020-2032)
Chapter 12. Company Profiles
12.1. Philips Healthcare
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Honeywell International Inc.
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. InTouch Health
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Cisco Systems, Inc.
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Medtronic plc
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Tunstall Healthcare Group
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. MDLive Inc.
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. VeeMed
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. eWellness Healthcare Corporation
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Neuro Rehab VR
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 774 402 6168
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
